# QbD Studio™ — Test Suite Readiness Declaration (TEST_READY)

## 1. Executive Declaration
The **Dual Track End-to-End (E2E) Test Suite** for the QbD & DoE Pharmaceutical Formulation Suite is **COMPLETE, VERIFIED, AND FULLY FUNCTIONAL**.

- **Total Test Files Across Platform**: 16 test files (100% passing)
- **Total Tests Passing**: 209 tests (0 failures, 0 skipped, 0 flaky)
- **Total E2E Tests Created**: 56 tests across 4 dedicated workflow suites
- **Execution Performance**: Full test run completes in ~1.14s on Vitest v4.1.11
- **Code Lint Quality**: 0 errors, 0 warnings across all E2E test files (`oxlint`)
- **TypeScript Type Safety**: 0 compiler errors (`tsc -b` compliant)

---

## 2. Four-Tier Test Suite Summary

All 4 test suites have been implemented under `src/test/e2e/` adhering to the 4-tier testing hierarchy defined in `TEST_INFRA.md`:

| Test Suite | Path | Tests | Scope & Key Coverage |
|---|---|:---:|---|
| **DSD Screening Workflow** | `src/test/e2e/dsdScreeningWorkflow.test.ts` | 16 | Jones & Nachtsheim (2011) foldover conference matrix, run count formula ($2m+1$ / $2m+3$), orthogonality of main effects ($X_1^T X_1 = cI$), unconfounding with 2FI ($X_1^T X_2 = 0$) and quadratic effects ($X_1^T X_i^2 = 0$), center point balance, natural unit mapping, regulatory CSV export, high-shear wet granulation 6-CPP screening. |
| **Desirability Optimization Workflow** | `src/test/e2e/optimizationWorkflow.test.ts` | 14 | Multi-response Derringer-Suich desirability functions (maximize, minimize, target, range), hybrid continuous Real-Coded Genetic Algorithm (RCGA) with SBX crossover and polynomial mutation, Nelder-Mead simplex local search polishing, Piepel (1983) effective bounds ($L_i^*, U_i^*$) consistency check, simplex projection, multi-CQA tablet formulation trade-off resolution. |
| **GxP Governance & 21 CFR Part 11** | `src/test/e2e/gxpGovernanceWorkflow.test.ts` | 13 | Pure TypeScript SHA-256 (FIPS 180-4 standard vectors), RFC 8785 canonical JSON serializer, sequential cryptographic hash-chain audit trail, 1-character tamper detection across timestamp, metadata, and snapshot payload, 3-tier electronic sign-off workflow (Analyst $\to$ Reviewer $\to$ Approver), Approver record locking. |
| **XAI & Model Benchmarking** | `src/test/e2e/xaiBenchmarkingWorkflow.test.ts` | 13 | Hurvich-Tsai (1989) small-sample corrected AICc, BIC, adjusted $R^2$, Garson's algorithm relative importance percentage ($\sum I_i = 100\%$), Olden's directional connection weights, Exact SHAP values ($k \le 8$) with efficiency/additivity verification ($\sum \phi_i = \hat{y} - \phi_0$), multi-model benchmarking table with Akaike weights ranking. |
| **Total E2E Tests** | `src/test/e2e/**` | **56** | **100% Pass Rate** |

---

## 3. Platform Test Suite Inventory (16/16 Passed)

```
Test Files (16 passed):
 ✓ src/test/e2e/dsdScreeningWorkflow.test.ts (16 tests)
 ✓ src/test/e2e/optimizationWorkflow.test.ts (14 tests)
 ✓ src/test/e2e/gxpGovernanceWorkflow.test.ts (13 tests)
 ✓ src/test/e2e/xaiBenchmarkingWorkflow.test.ts (13 tests)
 ✓ src/test/projectGovernance.test.ts (31 tests)
 ✓ src/services/statisticalReference.test.ts (43 tests)
 ✓ src/services/scientificCore.test.ts (14 tests)
 ✓ src/services/phase4Enhancements.test.ts (14 tests)
 ✓ src/services/phase2Enhancements.test.ts (10 tests)
 ✓ src/services/phase1Hotfixes.test.ts (11 tests)
 ✓ src/services/projectGovernance.test.ts (11 tests)
 ✓ src/services/discretePipeline.test.ts (6 tests)
 ✓ src/services/factorLevels.test.ts (5 tests)
 ✓ src/services/mixtureRounding.test.ts (5 tests)
 ✓ src/services/ternaryContour.test.ts (2 tests)
 ✓ src/services/neuralValidation.test.ts (1 test)

Total: 209 passed tests
```

---

## 4. How to Run the Tests

### 4.1. Run Entire Platform Test Suite
```bash
npm test
```
*On Windows PowerShell (if script execution policies apply):*
```powershell
cmd /c "npm test"
# Or
npx vitest run
```

### 4.2. Run Only E2E Test Suites
```bash
npx vitest run src/test/e2e/
```

### 4.3. Run Specific E2E Suite
```bash
npx vitest run src/test/e2e/dsdScreeningWorkflow.test.ts
npx vitest run src/test/e2e/optimizationWorkflow.test.ts
npx vitest run src/test/e2e/gxpGovernanceWorkflow.test.ts
npx vitest run src/test/e2e/xaiBenchmarkingWorkflow.test.ts
```

### 4.4. Verify Linter & Type Safety
```bash
npm run lint
npm run build
```

---

## 5. Regulatory Quality Assessment
1. **ICH Q8(R2) Pharmaceutical Development**: Design of Experiments (DSD screening), Design Space sweet-spot mapping, and multi-response optimization have verified mathematical correctness.
2. **FDA 21 CFR Part 11 & EU GMP Annex 11**: Cryptographic tamper-evident hash chaining, 1-character tamper detection, and 3-tier segregated electronic sign-offs are verified under rigorous adversarial test vectors.
3. **Data Integrity & Traceability**: All calculations are reproducible and deterministic using seeded pseudo-random number generators.

**Status**: READY FOR MILESTONE M5 AUDIT & SYSTEM RELEASE.
